neurogene.com (NGNE) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Neurogene Inc. (NGNE) miya genlarini tiklash uchun zamonaviy muhitni yaratmoqda, bunda EXACT metodi kamyob patologiyalarni davolash uchun aniq protein regulyatsiyasini ta'minlaydi. Biroq, biznes mo'rt Osiyo ta'minot zanjirlariga tayanadi va patent nizolariga duch kelmoqda, bu esa 0.02 bilan ifodalangan ko'rsatkichga ta'sir qiladi. Minimal ekologik ta'sir va qat'iy biokontrol sharoitida, quyida ko'rsatilgan NGNE aksiyalarining narx trayektoriyasi aktivning dinamikasini aks ettiradi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_NGNE_-_Neurogene-Inc._-_Long-Term-Debt-to-Equity-Ratio "NGNE - Neurogene Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 30.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Neurogene Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Neurogene Inc.|NGNE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi neurogene.com|NGNE - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Neurogene Inc.|NGNE - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Neurogene|Oraliq qoplash koeffitsiyenti neurogene.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:NGNE (Neurogene Inc)
Ushbu koeffitsiyent uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchab, moliyaviy leveraj darajasini va uzoq muddatli rejalashtirishda kompaniyaning tashqi qarzlarga bog'liqligini aniqlaydi. Qimmat gen terapiyasi ishlanmalariga investitsiya kiritayotgan Neurogene Inc. (NGNE) uchun uzoq muddatli qarzning kapitalga nisbatini baholash, patentlar tijoratlashtirilgunga va yuqori daromadli foyda erishilgunga qadar tadqiqotlar moliyalashtirilishining barqarorligi haqida tushuncha beradi.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HRMY (harmonybiosciences.com)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CBLL (ceribell.com)|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|OMER - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ACIU|VYGR - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. NMRA|SCLX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alpha Cognition|CGTX (Cognition Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|inhibikase.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|Assertio Therapeutics (ASRT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|vistagen.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics ATHE|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PEPG|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|RLMD - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|gracetx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|ANEW Medical (KLTO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH (revivapharma.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeurAxis Inc. (NRXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati HSDT|Uzoq muddatli qarzning kapitalga nisbati Passage Bio Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV (minervaneurosciences.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Addex Therapeutics Ltd. (ADXN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA (Cara Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Longboard Pharmaceuticals Inc (LBPH)|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAGE (sagerx.com)|Uzoq muddatli qarzning kapitalga nisbati SNPX|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati